Caike Biotechnology

Caike (Suzhou) Biotechnology Co., Ltd. is a life sciences company that develops and produces advanced research tools and instruments. Founded in 2018 in the Suzhou BioBay by several PhDs returning from the United States, the firm focuses on providing high-resolution data for life science researchers. The company's core technology, μ-MPF (Micro-scaled Multi-Physics coupled Force), underpins its product line, which includes a high-throughput single-cell photoconductive system and a single-molecule immunoassay analyzer. These products are designed to enhance research at the single-cell and single-molecule levels, enabling highly sensitive detection of biomarkers and functional screening.

Caike Biotechnology's business model is centered on developing and commercializing its proprietary platform technology and associated products, including instruments and reagents, for the life sciences and in-vitro diagnostics markets. The company serves researchers and clinicians, providing tools for applications such as the development and validation of low-abundance biomarkers, bioanalysis in drug development, and early disease detection and prognosis. For example, their single-molecule immunoassay system can directly analyze biomarkers in serum, plasma, and other biological fluids with ultra-high sensitivity.

Since its inception, Caike Biotechnology has achieved significant milestones and secured substantial funding. The company received an angel round investment in 2020 from IDG Capital and Borui Bio-medicine. This was followed in 2021 by Series A-1 and A-2 financing rounds, co-led by IDG Capital, Langyu Capital, and PerkinElmer Ventures, and a 150 million yuan Series B round co-led by Legend Capital, Hillhouse Capital, and CMG-SDIC Capital. In 2022, the company's single-molecule equipment received NMPA approval for IVD use, and its single-cell products were officially launched. The firm has also established a marketing center in Shanghai and an application technology center to support customer-driven R&D.

Keywords: single-molecule immunoassay, high-throughput single-cell analysis, life science research tools, microfluidics, biomarker detection, biotechnology, in-vitro diagnostics, µ-MPF technology, biological research instruments, single-cell photoconductive systems, low-abundance biomarkers, drug development tools, disease detection, immunoassay analyzer, high-resolution biological data, life science data, bioanalysis, diagnostics, single-cell level research, single-molecule level research